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Background: The importance of surface epithelium and epithelial inclusion cysts in the ovary arises from studies
demonstrating that these structures are susceptible to epithelial ovarian cancer development. The expression of
estrogen receptor alpha (ER alpha), androgen receptor (AR), in epithelial cells of the ovary from premenopausal and
postmenopausal women is interesting because sexual steroid hormones are involved in cell growth and
differentiation.
Methods: The presence of ER alpha, AR, and the orphan G protein-coupled receptor 30 (GPR30) was demonstrated
by immunofluorescence in ovaries obtained from 79 pre and postmenopausal patients, undergoing
histero-salpingo-oophorectomy for proliferative gynecological diseases. The proportion of patients that displayed
positive reaction for estrogen and androgen receptors in epithelial cells of the ovary was evaluated according to
menopausal status and associated pathology.
Results: The proportion of patients that displayed a positive receptor expression in the epithelial cells of the
ovarian surface and cortical inclusion cysts shows that ER alpha is present in 20 of 79 patients (0.25), AR in 33 of 79
(0.42) and GPR30 in 38 of 55 (0.69). There are no differences in ER alpha, AR, and GPR30 expression between pre
and postmenopausal patients and considering the associated pathology, proportions for ER alpha and GPR30 are
similar. The patients with cervical cancer show a higher proportion of AR expression in epithelial cells of the ovary,
which is statistically significant (P < 0.01) compared with patients with other proliferative diseases.
Conclusions: The presence of ER alpha, AR, and GPR30 in the surface epithelial ovarian cells and its derivatives are
observed with a proportion that is specific for each receptor. The proportion of expression for these receptors in
the epithelial cells of the ovary does not change after menopause. The proportion of ovaries with AR positive
epithelial cells in patients with cervical squamous carcinoma is higher compared with other gynecological
pathologies.
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The human ovary presents important changes after the
fourth decade of life; the number of follicles that are
recruited increases in the menopausal transition, the
production of estrogens is erratic and the level of
progesterone is diminished [1-3]. The follicular reserve
is markedly reduced at menopause, the ovary is devoid
of growing follicles and estradiol secretion is diminished;
meanwhile, testosterone levels are maintained, at least at
early postmenopause [4,5]. The ovary at postmenopause
is characterized by a reduced size with an irregular sur-
face displaying invaginations. An atrophic cortex without
follicles is replaced by a fibrous stroma covered by the
surface epithelium that is also found in surface clefts.
Epithelial inclusion cysts could be visualized in the
cortical region; the origin of these inclusion cysts in the
ovary has been related to invaginations of the surface
epithelium or to ruptures of the surface epithelium dur-
ing ovulation [6]. Alternatively, epithelial cells from the
Fallopian tubes may originate inclusion cysts after being
implanted into the ovary, as suggested by the occasional
presence of ciliated and secretory cells in cortical cyst
[7]. The importance of surface epithelium and epithelial
inclusion cysts arises from studies demonstrating that
these structures eventually presented dysplastic precur-
sor lesions and are susceptible to develop epithelial
ovarian cancer [8,9].
Steroid hormones interacting with their receptors
regulate several cellular events, such as differentiation,
hypertrophy and hyperplasia, modulating the transcrip-
tion of specific genes. The surface epithelium and
cortical inclusion cyst are exposed to changes in the
hormonal environment of the ovary, mainly in the peri-
menopausal and early postmenopausal period. Moreover,
the interaction of the epithelium, surrounding stroma
and steroid hormones would be important to maintain
the epithelial morphology and even in the development
of metaplasia and dysplasia processes. A previous study
reported that ovarian surface epithelium expressed
estrogen receptors (ER alpha and ER beta), androgen
receptor and progesterone receptor in primary cultures
obtained from postmenopausal women [10]. The pres-
ence of ER alpha has been demonstrated by immunohis-
tochemistry in postmenopausal women in the ovarian
surface epithelium and in epithelial inclusion cyst [11].
Similarly, AR has been detected in the female reproduct-
ive tract [12], including the surface epithelium and
cortical inclusion cyst of the ovary [11,13].
On the other hand, the orphan G protein-coupled
receptor 30 (GPR30) has been proposed to mediate non-
genomic action of estrogens, through the activation of
the epidermal growth factor receptor pathway, inducing
the expression of factors related to the progress of
the cell cycle in ovarian cancer cells [14,15]. To ourknowledge, the presence of GPR30 in epithelial struc-
tures of the human ovary has not been described.
The purpose of this study was to evaluate the presence
of ER alpha, AR, and GPR30 in the ovarian surface
epithelium and epithelial inclusion cysts in apparently




Ovary samples were obtained from 79 patients undergoing
hysterectomy and salpingo-oophorectomy for proliferative
gynecological diseases as approved by the Instituto
Nacional de Cancerologia, México DF. The buffered
formalin fixed samples were obtained from the Pathology
department during 2009–2012 and processed for
demonstrating the presence of ER alpha, AR, and GPR30
by immunofluorescence. The protocol of the study was
approved by the Ethical Board of the Instituto Nacional de
Cancerologia and Facultad de Medicina, Universidad
Nacional Autonoma de México.
Patients
Patients between 32 and 82 years of age were studied, of
which only 7/79 have less than 40, according to clinical
diagnosis 54 patients were postmenopausal and 25 premen-
opausal. Premenopause refers to the whole reproductive
period prior to the menopause. Postmenopause is defined
as 12 consecutive months of amenorrhea; patients with
induced menopause by other pathologies were not
included. Antecedents of pregnancy were reported in 70
patients and 66 refused hormonal contraception. According
to the indication of oophorectomy, patients had been
previously diagnosed with cervical squamous carcinoma
(n = 28), endometrial adenocarcinoma (n = 28), uterine
leiomyoma (n = 10) and other less frequent pathologies
(n = 13).
Immunofluorescence
The formalin fixed samples were paraffin embedded,
sectioned at 5 μm thickness and placed on coated glass
slides (Biocare Medical). Slides were kept at 56°C over-
night, sections were deparaffinized by incubation in xilol
during 15 minutes, then, rehydrated through a graded
series of ethanol and water. After hydratation, samples
were exposed to antigen retrieval with 1X Diva Decloaker
(Biocare Medical) in a pressure cooker for 10 minutes.
Slides were incubated overnight at 4°C with the following
polyclonal rabbit primary antibodies: anti-AR 1:50 (Santa
Cruz Biotechnology, Inc.), anti-ER alpha 1:50 (Santa
Cruz Biotechnology, Inc.) and anti-GPR30 1:600
(ab39742, Abcam antibodies) and further incubated with
a secondary antibody goat-anti-rabbit Cy3 (AP187C,
Millipore). In order to identify epithelial cells, the slides
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mouse monoclonal anti pan-cytokeratin AE1/AE3 + 8/18
(CM162C) diluted 1:100, Biocare Medical). The samples
were washed with PBS and incubated with the secondary
antibody Alexa Fluor 647 donkey anti-mouse (A31571),
(Invitrogen). Nucleus was stained with 4′, 6-Diamidino-
2-Phenylindole, Dihydrochloride (DAPI) (Sigma Chemical).
Slides were mounted with VectaShield mounting medium
(Vector Laboratories). The immunolabeled slices were
observed using a confocal laser microscope Leica TCS SP5
(Leica Microsystems, Wetzlar, Germany). Negative con-
trols involved the substitution of the primary antibody with
either PBS or with pre-immune immunoglobulins; for AR
and ER alpha, primary antibodies were incubated with a
blocking peptide. Positive control tissues were included in
each immune reaction. The epithelial cells present in the
surface of the ovary, in epithelial clefts connected to the
surface, and epithelial cells of cortical inclusion cysts were
evaluated; follicular cysts were not included. The presence
of labeled epithelial cells in any of these locations with an
H-score ≥ 50 was considered positive. Positive reaction for
ER alpha and AR was detected through nuclear staining,
for GPR30 the labeling was observed in the cytoplasm.
The classification of double blinded samples was assessed
by two independent observers.
Statistical methods
Frequency of positive reactions for each receptor was
evaluated for association (chi-square) and comparison of
proportions (“Z” value for normal distribution). P value
less than 0.05 was considered significant.Figure 1 Immunofluorescence for ER alpha, AR, and GPR30 in ovarian
are visualized in nuclei of epithelium of cortical cyst, GPR30 is observed in
indicates epithelial cells; DAPI (blue) stains the nucleus as displayed in mer
for GRP30.Results
Positive reactions for ER alpha, AR y GPR30 were
observed in epithelium of ovary sections; co-localization
with cytokeratin allowed the identification of epithelial
cells in the ovarian surface and cortical cysts. Nuclear
staining with DAPI indicated the ER alpha and AR
nuclear localization (Figure 1).
The presence of ER alpha was observed in 0.25 of the
total samples; the proportion of AR positive samples was
0.42; while GPR30 was observed in 0.69 of the samples.
There was no difference in proportions between
premenopausal and postmenopausal women (Table 1).
Positive reactions for ER alpha, AR, and GPR30 in
epithelial cells of cortical inclusion cyst and positive cells
in the surface epithelium or epithelial clefts in the same
sample were compared. Relationship of positive labeling
in both locations has been observed in 78% of ovaries.
On the other hand, the association between ER alpha,
AR, and GPR30 positive reactions in the same sample
was not significant.
Proportions of ER alpha, AR, and GPR30 immunore-
active epithelial cells in the ovary of patients with
cervical squamous carcinoma versus patients with other
pathologies were compared. There were no differences
in the expression of ER alpha and GPR30 between the
two groups of patients. The presence of AR in the ovary
was significantly higher in the cervical cancer patients
than other pathologies analyzed (0.64 vs. 0.29) (Table 2).
This increment in the proportion of AR was observed in
the ovary of premenopausal and postmenopausal women
with similar values.epithelial cells of postmenopausal women. ER alpha, AR (green)
the cytoplasm of the ovarian surface epithelium. Cytokeratin (red)
ge images. Scale bars indicate 50 μm for AR and ER alpha and 10 μm
Table 1 Expression of ER alpha, AR and GPR30 in ovarian
epithelial cells in pre and postmenopausal patients
ER alpha AR GPR30
Premenopause 7/25 8/25 12/21
0.28 0.32 0.57
Postmenopause 13/54 25/54 26/34
0.24 0.46 0.77
Total 20/79 33/79 38/55
0.25 0.42 0.69
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The detection of immunoreactivity by confocal micros-
copy is a reliable method to evaluate colocalization;
moreover, immunofluorescence also prevents changes in
the labeling of epithelial cells in relation to the exposure
time, as could be observed in techniques based on
enzymatic reactions.
In our study, not all ovarian samples were positive for
ER alpha, AR, and GPR30 in epithelial cells from the
surface epithelium or the cortical inclusion cysts. The
immunoreactivity for ER alpha is the least frequent in
ovary samples, only a quarter of the ovaries were
positive. The presence of AR and GPR30 was observed
in about the half of the ovaries, 0.42 and 0.69, respect-
ively. Previous studies have shown the expression of the
mRNA for ER alpha, AR, and PR in four primary cul-
tures of surface epithelial cells obtained from ovaries of
postmenopausal women [10]. Moreover, the expression
of AR, PR, and ER alpha has also been described in
cells of the surface epithelium and epithelial inclusion
cysts of ovaries of postmenopausal women; the ex-
pression of AR and PR remain unchanged, but inten-
sity for ER alpha decreases in relation to years after
menopause [11]. Our results do not detect changes in
the frequency of positive reaction for ER alpha, AR,
and GPR30 in the ovary of premenopausal and
postmenopausal women; this discrepancy could be
explained because the present study evaluates propor-
tion of positive reaction observed in the ovary, with-
out discriminating the intensity of reactions.
The expression of the hormone receptors is detected
in epithelial cells of the ovarian surface and epithelial
inclusion cysts; however, in about 20% of ovaries, theTable 2 Expression of ER alpha, AR and GPR30 in ovarian
epithelial cells according with associate pathology
ER alpha AR GPR30






*P < 0.01 vs. Endometrial adenocarcinoma, leiomyoma and others.
Z value = 3.01.positive reaction does not coincide in both locations.
This finding suggests that cortical inclusion cysts could
be a heterogeneous structure, as it has been proposed in
relation to the metaplasic changes detected in the
epithelium of inclusion cysts [16]. However, changes
caused by the tissue processing techniques could not be
totally discarded.
The increase in the proportion of AR positive immu-
noreactivity in epithelial cells of the ovary in women
with cervical squamous carcinoma is an unexpected
finding. It seems to be specific because the proportion
of ER alpha and GPR30 is similar in patients with
cervical carcinoma compared with other proliferative
pathologies.
The presence of androgen receptor in the epithelial
cells of the ovary could represent the constitutive ex-
pression of this receptor in female reproductive tissues.
Then, the increase in the frequency of AR that we ob-
served in epithelial cells of the ovary would be associated
to changes in androgen receptor expression in cervix. A
previous study indicates that androgen receptor expres-
sion changes in invasive squamous cell carcinoma of the
cervix compared with normal cervical epithelium [17].
Moreover, AR regulates the expression of key factors
involved in cell proliferation and invasion, as cyclin
D1, TGFbeta1 and E-cadherin [18]. Therefore, extensive
studies will be required to corroborate the relation-
ship of cervical carcinoma with androgen receptor
expression.
Alternatively, human papillomavirus (HPV) infection
could simultaneously affect cervix and other reproduct-
ive organs. There is evidence of the presence of HPV
(types 16, 18, 31, 33, 53) in the human ovary [19] and
HPV transcripts were detected in uterine endometrioid
carcinoma [20]. Changes in the expression of androgen
receptor in the ovary would be related to HPV infection.
Similar to previous findings in cervix describing a high
estrogen receptor expression related with HPV infection;
this observation is not dependant on a particular HPV
type [21]. Future studies will address the relationship of
HPV infection with AR expression in epithelial cells of
the ovary.Conclusions
The expression of ER alpha, AR, and GPR30 should
be considered within the phenotype of the surface
epithelial ovarian cells and its derivatives. The
proportion of positive expression for these receptors
in the epithelial cells of the ovary does not change
after menopause. The proportion of ovaries with AR
positive epithelial cells is highest in patients with
cervical squamous carcinoma compared with other
gynecological pathologies.
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